<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJCD</journal-id><journal-title-group><journal-title>Open Journal of Clinical Diagnostics</journal-title></journal-title-group><issn pub-type="epub">2162-5816</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojcd.2019.94008</article-id><article-id pub-id-type="publisher-id">OJCD-96377</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Anemia in the Elderly: Frequency and Etiologies at University Hospital Center of Point G
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sy</surname><given-names>Djibril</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Traoré</surname><given-names>Abdel Kader</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kaya</surname><given-names>Assétou Soukho</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Traoré</surname><given-names>Djenebou</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Gozo</surname><given-names>Jean-Jonathan Cocou</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Keïta</surname><given-names>Zakaria</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Dembelé</surname><given-names>Ibrahima Amadou</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Cissoko</surname><given-names>Mamadou</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Keïta</surname><given-names>Kaly</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sangaré</surname><given-names>Barry Boubacar</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mallé</surname><given-names>Mamadou</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sy</surname><given-names>Seydou</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Dembélé</surname><given-names>Mamadou</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Traoré</surname><given-names>Hamar Alassane</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>1Department of Internal Medicine of University Hospital Center of Point G, Bamako, Mali</addr-line></aff><aff id="aff4"><addr-line>Department of Nephrology of University Hospital Center of Point G, Bamako, Mali</addr-line></aff><aff id="aff1"><addr-line>Department of Internal Medicine of University Hospital Center of Point G, Bamako, Mali</addr-line></aff><aff id="aff2"><addr-line>General Secretary of the Association “Rabies in West Africa—Mali”, Bamako, Mali</addr-line></aff><pub-date pub-type="epub"><day>14</day><month>11</month><year>2019</year></pub-date><volume>09</volume><issue>04</issue><fpage>115</fpage><lpage>125</lpage><history><date date-type="received"><day>31,</day>	<month>August</month>	<year>2019</year></date><date date-type="rev-recd"><day>12,</day>	<month>November</month>	<year>2019</year>	</date><date date-type="accepted"><day>15,</day>	<month>November</month>	<year>2019</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
   <b>Introduction:</b> Older people are exposed to particular health problems that must be taken into account, including anemia defined by the World Health Organization (WHO) in people aged 65 and over hemoglobin &lt; 13 g/dl in men and &lt; 12 g/dl in women. <b>Objectives:</b> To determine the frequency of anemia, to describe its clinical and paraclinical aspects, and to determine the etiologies. <b>Material and Methods:</b> We conducted a cross-sectional study with prospective data collection that took place in the Department of Internal Medicine of the Point G CHU in Mali from January 1<sup>st</sup>, 2018 to August 31<sup>st</sup>, 2018, covering all elderly patients. At least 65 years old hospitalized and/or having consulted and presenting with anemia. Anemia was defined as Hb &lt; 13 g/dl in men and &lt; 12 g/dl in women (WHO definition). Biological markers were collected at admission. <b>Results:</b> Anemia was observed in 42 patients in 160 elderly patients, a prevalence of 26%, the age of our patients ranged from 65 to 90 years. The sex ratio was 1.33. Fifty percent (50%) of the patients had high blood pressure as antecedents. Weight loss was found in 69% of cases; 47.6% of patients had dyspnea on admission. Tachycardia was the physical sign associated with anemia present in 85.7% of them. The mean hemoglobin level was 9.2 g/dl &#177; 2.03: thus 50% of the subjects had microcytic and or hypochromic anemia. The etiologies found were infectious in 31.0% of cases, inflammatory in 31.0% of cases, renal in 14.2% of cases. Chronic hemorrhage, acute haemorrhage, hemolysis accounted for 2.4% each. We observed 9.5% of unexplained causes. <b>Conclusion:</b> The frequency of anemia is high. Nearly half of the geriatric population has anemia. The lack of means and the nonperformance of the technical platform to perform all examinations in the etiological research of anemia have a significant impact on the rate of unexplained anemias. 
 
</p></abstract><kwd-group><kwd>Anemia</kwd><kwd> Elderly</kwd><kwd> Internal Medicine</kwd><kwd> CHU Point G</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Seniors are exposed to particular physical and mental health issues that need to be addressed [<xref ref-type="bibr" rid="scirp.96377-ref1">1</xref>]. Anemia is one of these conditions [<xref ref-type="bibr" rid="scirp.96377-ref2">2</xref>]. According to the World Health Organization (WHO), the concentration of hemoglobin (Hb) that defines the presence of anemia in the elderly would be &lt; 13 g/dl in men and &lt; 12 g/dl in women [<xref ref-type="bibr" rid="scirp.96377-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.96377-ref4">4</xref>]. With these definitions, between 1993 and 2005, anemia affected 24% of the elderly in the world (164 million people), but with significant regional differences [<xref ref-type="bibr" rid="scirp.96377-ref5">5</xref>].</p><p>In Belgium, an older study (in 1976) already reported a prevalence of 35.1% of anemia in the elderly with an age ≥ 65 years [<xref ref-type="bibr" rid="scirp.96377-ref6">6</xref>]. These studies show that anemia is not only a public health problem but also a plague at the heart of geriatrics.</p><p>In Africa, anemia is frequent. Specifically in Mali, a previous study in 1980 indicated an anemia prevalence of 9.1% in subjects aged 60 and over [<xref ref-type="bibr" rid="scirp.96377-ref7">7</xref>], while another in 2015 reported an 86.3% anemia rate in subjects aged 65 years and older [<xref ref-type="bibr" rid="scirp.96377-ref8">8</xref>]. This could be explained by the lifestyle and nutrition changes that have occurred over the years.</p><p>Anemia is a common condition in people over 65 years of age with an estimated prevalence of 11% in men and 10.2% in women [<xref ref-type="bibr" rid="scirp.96377-ref9">9</xref>]. Contrary to certain beliefs, senile anemia does not exist and must not be neglected in an elderly person [<xref ref-type="bibr" rid="scirp.96377-ref10">10</xref>]. Under each anemia lies a probable etiology, 30% of cases of anemia are classified unexplained due to lack of sufficient exploration.</p><p>Even though the prevalence of anemia in adult subjects, in general, has been studied a lot in Mali, its frequency and etiologies compared with the age group of 65 years and over have been less studied, hence the interest of our study.</p></sec><sec id="s2"><title>2. Patients and Method</title><p>We conducted a cross-sectional study with prospective data collection spanning the period from January 1, 2018 to August 31, 2018. Our study population included patients aged 65 years and older. All patients were aged 65 years and over, of both sexes, have a hemoglobin level &lt; 13 g/dl in men and &lt; 12 g/dl in women.</p><p>We consulted the registers and all the files of patients who were hospitalized and/or seen externally in the Internal Medicine department in order to gather additional information as needed. Clinical evaluation data, additional examinations and the selected diagnosis(s) were mentioned as variables measured on a pre-established standardized individual survey form with socio-demographic sections; anamnestic data; physical examinations; biological examinations.</p><p>Data entry was done with the 2013 Office Pack and its data analysis with SPSS 22.0 for Windows. Fisher’s exact test was the statistical test used with a risk α = 0.05.</p></sec><sec id="s3"><title>3. Results</title><p>From January 1, 2018 to August 31, 2018, 160 people aged 65 and over were hospitalized and or seen in the outpatient department of internal medicine at the University Hospital Center of Point G. Among these patients, we found 42 cases of anemia which gave a prevalence of 26%. Men accounted for 57.1% of cases with a sex ratio of 1.33. Mean age was 72.14 &#177; 7.67 with extremes at 65 and 90 years (<xref ref-type="table" rid="table1">Table 1</xref>).</p><p>Among the antecedents, high blood pressure was found in 21 patients slimming was the general sign present in 69.0% of cases, breathlessness in 47.6% and tachycardia in 85.7% (<xref ref-type="table" rid="table2">Table 2</xref>).</p><p>More than one third (38.1%) of patients had a hemoglobin between 8.1 to 10 g/dl with a mean of 9.2 &#177; 2.03 g/dl.</p><p>The Mean Corpuscular Volume (MCV) less than 80 fl was found in 50.0% of cases, the mean corpuscular hemoglobin concentration was less than 33 g/dl in 66.7% and the reticulocyte level was less than 120 &#215; 10<sup>3</sup>/mm<sup>3</sup> in 61.9% (<xref ref-type="table" rid="table3">Table 3</xref>).</p><p>Microcytic and or hypochromic anemia was found in 50.0% of patients (<xref ref-type="table" rid="table2">Table 2</xref>).</p><p>A CRP &gt; 5 mg/l was found in 59.5% of the cases. Forty-seven point six percent (47.6%) of patients had a glomerular filtration rate greater (GFR) than 100 ml/min/1.73m<sup>2</sup>.</p><p>At the digestive fibroscopy (esophagus, gastric and duodenal), high digestive bleeding was estimated for 7.1%; four cases of erythematous gastritis, two cases for both antral ulcer and esophageal varices and one case for each of the following abnormalities: erosive arthritis, gastroesophageal invagination and the antral tumor.</p><p>The main etiologies were infectious, neoplastic and systemic, 31.0% respectively (n = 13), and related to chronic renal failure 14.2% (n = 6). Anemia of unexplained causes was found in 9.5% (<xref ref-type="table" rid="table3">Table 3</xref>).</p><p>There is a significant statistical link between the type of anemia and the nature of the etiology (p = 0.0048) (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p></sec><sec id="s4"><title>4. Comments</title><sec id="s4_1"><title>4.1. Limitations of the Study</title><p>Anemia was only explored in 42 patients, which gives us a rough idea of the etiologies. In addition to small data, the early death of patients, the exit of patients against medical advice and the lack of financial means to carry out biological explorations have limited a total view of all patients’ medical characteristics.</p></sec><sec id="s4_2"><title>4.2. Frequency</title><p>Over a period of 8 months among 160 patients aged 65 and over hospitalized</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Distribution by socio-demographic data of antecedents and signs</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Gender</th><th align="center" valign="middle" >Effective</th><th align="center" valign="middle" >%</th></tr></thead><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >57.1</td></tr><tr><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >42.9</td></tr><tr><td align="center" valign="middle" >Age Group (years)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >65 - 74</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >71.4</td></tr><tr><td align="center" valign="middle" >75 - 84</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >16.7</td></tr><tr><td align="center" valign="middle" >≥85</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >11.9</td></tr><tr><td align="center" valign="middle" >Antecedents</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Hypertension</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >50</td></tr><tr><td align="center" valign="middle" >Diabetes</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >17</td></tr><tr><td align="center" valign="middle" >Gastroduodenal ulcer</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >24</td></tr><tr><td align="center" valign="middle" >Viral hepatitis</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >10</td></tr><tr><td align="center" valign="middle" >Renal failure</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2</td></tr><tr><td align="center" valign="middle" >HIV infection</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2</td></tr><tr><td align="center" valign="middle" >Other</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >19</td></tr><tr><td align="center" valign="middle" >General Signs</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Anorexia</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >47.6</td></tr><tr><td align="center" valign="middle" >Emaciation</td><td align="center" valign="middle" >29</td><td align="center" valign="middle" >69</td></tr><tr><td align="center" valign="middle" >Asthenia</td><td align="center" valign="middle" >27</td><td align="center" valign="middle" >64.3</td></tr><tr><td align="center" valign="middle" >Functional Signs</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Dizziness</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >14.3</td></tr><tr><td align="center" valign="middle" >faintness</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2.4</td></tr><tr><td align="center" valign="middle" >Fall</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2.4</td></tr><tr><td align="center" valign="middle" >shortness</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >47.6</td></tr><tr><td align="center" valign="middle" >palpitations</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >35.3</td></tr><tr><td align="center" valign="middle" >Physical Signs</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Pallor</td><td align="center" valign="middle" >38</td><td align="center" valign="middle" >90.6</td></tr><tr><td align="center" valign="middle" >Polypnoea</td><td align="center" valign="middle" >33</td><td align="center" valign="middle" >78.6</td></tr><tr><td align="center" valign="middle" >Tachycardia</td><td align="center" valign="middle" >36</td><td align="center" valign="middle" >85.7</td></tr><tr><td align="center" valign="middle" >hypotension</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >42.9</td></tr><tr><td align="center" valign="middle" >Heart murmur</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >9.3</td></tr></tbody></table></table-wrap><table-wrap-group id="2"><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Distribution according to erythrocyte constancy and type of anemia (n = 42)</title></caption><table-wrap id="2_1"><table><tbody><thead><tr><th align="center" valign="middle" >Hb level (g/dl)</th><th align="center" valign="middle" >Effective</th><th align="center" valign="middle" >%</th></tr></thead><tr><td align="center" valign="middle" >≤6</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >9.5</td></tr><tr><td align="center" valign="middle" >6.1 - 8.0</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >16.7</td></tr><tr><td align="center" valign="middle" >8.1 - 10</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >38.1</td></tr></tbody></table></table-wrap><table-wrap id="2_2"><table><tbody><thead><tr><th align="center" valign="middle" >&gt;10</th><th align="center" valign="middle" >15</th><th align="center" valign="middle" >35.7</th></tr></thead><tr><td align="center" valign="middle" >VGM (fl.)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&lt;80</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >50.0</td></tr><tr><td align="center" valign="middle" >80 - 100</td><td align="center" valign="middle" >19</td><td align="center" valign="middle" >45.2</td></tr><tr><td align="center" valign="middle" >&gt;100</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >4.8</td></tr><tr><td align="center" valign="middle" >CCMH (g/dL)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&lt;33</td><td align="center" valign="middle" >28</td><td align="center" valign="middle" >66.7</td></tr><tr><td align="center" valign="middle" >≥33</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >33.3</td></tr><tr><td align="center" valign="middle" >Reticulocyte Rate (&#215;10<sup>3</sup>/mm<sup>3</sup>)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&lt;120</td><td align="center" valign="middle" >26</td><td align="center" valign="middle" >61.9</td></tr><tr><td align="center" valign="middle" >≥120</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >33.3</td></tr><tr><td align="center" valign="middle" >not done</td><td align="center" valign="middle" >02</td><td align="center" valign="middle" >4.8</td></tr><tr><td align="center" valign="middle" >Type of Anemia</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Microcytic and/or hypochromic</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >50.0</td></tr><tr><td align="center" valign="middle" >Regenerative normocytary</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >30.9</td></tr><tr><td align="center" valign="middle" >Artere generative normocyte</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >14.3</td></tr><tr><td align="center" valign="middle" >Macrocytic</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >4.8</td></tr></tbody></table></table-wrap></table-wrap-group><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Distribution by etiologies</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Etiologies</th><th align="center" valign="middle" >Effective</th><th align="center" valign="middle" >%</th></tr></thead><tr><td align="center" valign="middle" >Infectious</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >31.0</td></tr><tr><td align="center" valign="middle" >Inflammatory (neoplasia and autoimmune disease)</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >31.0</td></tr><tr><td align="center" valign="middle" >Chronic bleeding</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >9.5</td></tr><tr><td align="center" valign="middle" >Chronic kidney disease</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >14.2</td></tr><tr><td align="center" valign="middle" >Acute hemorrhage</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2.4</td></tr><tr><td align="center" valign="middle" >Hemolysis</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2.4</td></tr><tr><td align="center" valign="middle" >unexplained anemia</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >9.5</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >42</td><td align="center" valign="middle" >100.0</td></tr></tbody></table></table-wrap><p>and consulted in the internal medicine department, we included 42 patients according to our criteria, an anemia prevalence of 26% in the population geriatric.</p><p>This result is similar to that of Callera [<xref ref-type="bibr" rid="scirp.96377-ref11">11</xref>] which found 18.6% in Brazil, but different from those found by Beyne [<xref ref-type="bibr" rid="scirp.96377-ref12">12</xref>] in France with 47%, Tolo [<xref ref-type="bibr" rid="scirp.96377-ref13">13</xref>] in Mali or 47.73%.</p><p>Roth [<xref ref-type="bibr" rid="scirp.96377-ref14">14</xref>] also in France found a frequency of 41% of anemia as Zulfiqar [<xref ref-type="bibr" rid="scirp.96377-ref15">15</xref>] with a frequency of 47.5% within the geriatric population.</p><p>This difference could be explained by the fact that the studies Beyne [<xref ref-type="bibr" rid="scirp.96377-ref12">12</xref>], Roth [<xref ref-type="bibr" rid="scirp.96377-ref14">14</xref>] and Zulfiqar [<xref ref-type="bibr" rid="scirp.96377-ref15">15</xref>] included a larger number of cases than our study.</p></sec><sec id="s4_3"><title>4.3. Age</title><p>The mean age was 72.14 &#177; 7.67 with extremes of 65 and 90 years.</p><p>These results are similar to those found in Mali by Tolo [<xref ref-type="bibr" rid="scirp.96377-ref13">13</xref>] and Sandji [<xref ref-type="bibr" rid="scirp.96377-ref8">8</xref>] who found respectively 73.39 years and 73.8 years. But these data are inferior to those found in the West.</p><p>Beyne [<xref ref-type="bibr" rid="scirp.96377-ref12">12</xref>], Roth [<xref ref-type="bibr" rid="scirp.96377-ref14">14</xref>] and Zulfiqar [<xref ref-type="bibr" rid="scirp.96377-ref15">15</xref>] respectively reported 85.8; 89.5 and 86.7 years as the average age.</p><p>This difference could be explained by the fact that these studies were conducted in countries with a high life expectancy with a relatively aging population.</p></sec><sec id="s4_4"><title>4.4. Gender</title><p>Male predominance (57.1%) was observed in our study with a sex ratio of 1.33; similar predominance to some studies in Mali: 1.71 Tolo [<xref ref-type="bibr" rid="scirp.96377-ref13">13</xref>]; 1.94 Roth [<xref ref-type="bibr" rid="scirp.96377-ref14">14</xref>]; 2.07 Sandji [<xref ref-type="bibr" rid="scirp.96377-ref8">8</xref>]. On the other hand, in several European studies, the predominance is feminine.</p><p>Zulfiqar [<xref ref-type="bibr" rid="scirp.96377-ref15">15</xref>] found a sex ratio of 0.58 and Beyne [<xref ref-type="bibr" rid="scirp.96377-ref12">12</xref>], with a sex ratio of 0.52 and Roth [<xref ref-type="bibr" rid="scirp.96377-ref14">14</xref>] with a sex ratio of 0.50. This difference could be explained to the fact that the proportion of women is higher than that of men in Western populations.</p></sec><sec id="s4_5"><title>4.5. Hematological Aspects</title><p>The hemoglobin slice [8.1 - 10] g/dl represented 38.1% and the mean hemoglobin level was 9.2 &#177; 2.03 g/dl. This result is close to that of Tolo [<xref ref-type="bibr" rid="scirp.96377-ref13">13</xref>] who found an average hemoglobin level of 8.93 g/dl in Mali, but lower than those found by other authors as Beyne [<xref ref-type="bibr" rid="scirp.96377-ref12">12</xref>] (10 g/dl); Roth [<xref ref-type="bibr" rid="scirp.96377-ref14">14</xref>] (10.6 g/dl); and Callera [<xref ref-type="bibr" rid="scirp.96377-ref11">11</xref>] (10.9 g/dl).</p><p>The delay of admission of patients to hospitals could explain these differences of figures because in our countries the use of health care is not systematic, patients wait until the symptoms are more or less troublesome or disabling.</p></sec><sec id="s4_6"><title>4.6. Type of Anemia</title><p>Microcytic and/or hypochromic anemia was the most represented type with 50.0% of cases which is superior to that found by Tolo [<xref ref-type="bibr" rid="scirp.96377-ref13">13</xref>] with a rate of 30% of microcytic and/or hypochromic anemia. This difference could be explained by the variable size of the samples but also by the frequency of the predominant etiologies at the period during which the studies were conducted.</p></sec><sec id="s4_7"><title>4.7. Etiologies</title><p>During our study, 9.5% of cases of anemia were classified as unexplained. These results are superior to those described in the literature.</p><p>Tolo [<xref ref-type="bibr" rid="scirp.96377-ref13">13</xref>] reported 6.9%, Beyne [<xref ref-type="bibr" rid="scirp.96377-ref12">12</xref>] 5%, and Roth [<xref ref-type="bibr" rid="scirp.96377-ref14">14</xref>], 1% unexplained anemia.</p><p>This difference is explained by the fact that during our study, these cases considered unexplained have not been fully explored due to a lack of financial means. The early death factor is also partly the cause. On the other hand, the efficient technical platforms involved in the etiological research of the anemias in the countries where the studies of Beyne [<xref ref-type="bibr" rid="scirp.96377-ref12">12</xref>] and Roth [<xref ref-type="bibr" rid="scirp.96377-ref14">14</xref>] have been carried out have allowed to find an etiology in the majority of cases.</p></sec></sec><sec id="s5"><title>5. Conclusions</title><p>The frequency of anemia is high, one quarter (26%) of the geriatric population has anemia. Very usually it is manifested by shortness of breath and palpitations. There is no senile anemia. The most represented type is microcytic or hypochromic anemia.</p><p>A simple etiological assessment makes it possible to find an etiology in 90.5% of cases; the etiologies are multiple, most often it is of inflammatory origin.</p><p>The lack of financial means and the technical platform for the etiological research of anemia have a significant impact on the rate of unexplained anemias (9.5% in Mali).</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s7"><title>Cite this paper</title><p>Djibril, S., Kader, T.A., Soukho, K.A., Djenebou, T., Cocou, G.J.J., Zakaria, K., Amadou, D.I., Mamadou, C., Kaly, K., Boubacar, S.B., Mamadou, M., Seydou, S., Mamadou, D. and Alassane, T.H. (2019) Anemia in the Elderly: Frequency and Etiologies at University Hospital Center of Point G. Open Journal of Clinical Diagnostics, 9, 115-125. https://doi.org/10.4236/ojcd.2019.94008</p></sec><sec id="s8"><title>Annex</title><p>Pre-established standardized individual survey form</p><p>A—Sociodemographic data</p><p>- Age: ............ years</p><p>- Sex: / ....... /</p><p>1 = Male, 2 = Female</p><p>B—Antecedent</p><p>- Medical</p><p>1. Diabetes: / ___ / 1 = Yes 2 = No</p><p>2. AVC: / ___ / 1 = Yes 2 = No</p><p>3. HTA: / ___ / 1 = yes 2 = No</p><p>4. Peptic ulcer / ___ / 1 = Yes 2 = No</p><p>5. Sickle cell disease / ___ / (1 = yes, 2 = no)</p><p>6. Asthma / ___ / (1 = yes, 2 = no)</p><p>7. HIV / ___ / (1 = yes, 2 = no) (............................)</p><p>8. Viral hepatitis / ___ / (1 = yes, 2 = no) (............................)</p><p>9. Other</p><p>........................................................................................................................................................................................................................................................................................</p><p>- Surgical</p><p>........................................................................................................................................................................................................................................................................................</p><p>- Notions of drug intake (1 = yes, 2 = no) /....................../</p><p>If yes …………………………………………………………………………</p><p>Lifestyle: (1 = yes, 2 = no)</p><p>-Alcohol: / __ / ............................</p><p>- Tobacco: / __ / if yes: / __ / (1 ≤ to 10 P/A, 2 = 10 to 20 P/A, 3 ≥ to 20 P/A)</p><p>- Cardiovascular risk factors: Diabetes: / __ / - HTA: / __ / - Obesity: / __ / - Sedentarity: / __ /</p><p>- Other: / __ / ..................</p><p>- Concept of medication taken: / __ /</p><p>........................................................................................................................................................................................................................................................................................</p><p>C—Signs</p><p>- Functional signs of anemia: / ............ /</p><p>1 = vertigo; 2 = lipothymia; 3 = fall; 4 = headache; 5 = shortness of breath; 6 = palpitations</p><p>- Physical examination</p><p>1. General Exam: (1 = yes, 2 = no)</p><p>Size (in meters): ............ Weight (in kg): ..........</p><p>BMI (Kg/m<sup>2</sup>): .................. Temperature (in ˚C): .........</p><p>TA (in mmHg): .... ............. Pulse (pulsations/minute) = ................</p><p>Respiratory rate:…………..…</p><p>Anorexia: / __ / Slimming: / __ / Asthenia: / __ / Chills: / __ /</p><p>Sweat: / __ / Cutaneous conjunctivo-mucous paleness: / ___ / Icterus: / __ /</p><p>Headache: / __ / Vomiting: / __ / Dehydration: / __ / IMO: / __ /</p><p>D—Paraclinical examinations</p><p>1. Hemogram:</p><p>GR = .........................Hte = ....................Hb = .........................VGM =.........................</p><p>MCH = = .....................................CCMH..R&#233;ticulocytes = ..................</p><p>GB = ....................GRA. = ...................................PN = PE = ................</p><p>PB = ..................... Lym = M = .........................................................</p><p>Toxic granulations = .......................Blastes = ..................................</p><p>Type of anemia: / _____/(1—microcytic and/or hypochromic; 2—normocytic</p><p>Regenerative; 3—normocytic arterenative; 4—macrocytic)</p><p>2. Microcytic anemia</p><p>Martial Assessment: (1—increased; 2—normal; 3—lowered; 4—No Done)</p><p>Ferritin: / ___ / Transferrin: / ___ / Serum iron: / ___ /; CST: / ___ /</p><p>Inflammatory status: (1—increased; 2—normal; 3—lowered; 4—No Done)</p><p>VS: / ___ / CRP: / ___ / H</p><p>Electrophoresis of Hb: / ____/ (1—normal; 2—sickle cell disease; 3—thalassemia; 4—No Made)</p><p>Endoscopy:</p><p>Fibroscopy: / ___ / (1 = normal, 2 = bleeding, 3 = other, 4 = not done)</p><p>Location bleeding ...........................................................................................................</p><p>Other.................................................................................................................................</p><p>Ano-rectoscopy: / ___ / (1 = normal, 2 = bleeding, 3 = other, 4 = not done)</p><p>Location bleeding ....................................................................</p><p>Other……………………………………………………………...……………….</p><p>Colonoscopy: / ___ / (1 = normal, 2 = bleeding, 3 = other, 4 = not done)</p><p>Location bleeding ....................................................................</p><p>Other.................................................................................................................................</p><p>Coombs test: / ___ / (1—agglutination, 2—negative)</p><p>IDRT / ___ / 1 = negative; 2 ≥ 10; 3 ≥ 15</p><p>Blood culture / ___ / 1 = sterile; 2 = sepsis. If sepsis: germ</p><p>(..................................................................... ..............)</p><p>Thick drop / ___ / 1 = positive; 2 = negative</p><p>ECBU / ___ / 1 = sterile; 2 = urinary tract infection</p><p>If infection: germ (s) ...............................................................</p><p>Leukocytes / ...... / 1 ≤ 10,000/ml; 2 ≥ 10,000/ml</p><p>- Hatiaties / ...... / 1 ≤ 5000/ml; 2 ≥ 5000/ml</p><p>- Antibiogram: .........................................................</p><p>Hormonal balance:</p><p>TSHus: ....................; FT4: ..................; TRH: .........</p><p>FT3: ................;</p><p>Folate: / ___ / (1—increased; 2—normal; 3—lowered; 4—No Done)</p><p>VB12: / ___ / (1—increased; 2—normal; 3—lowered; 4—No Done)</p><p>G6PD: / ___ / (1—increased; 2—normal; 3—lowered; 4—No Done)</p><p>Myelogram:</p><p>........................................................................................................................................................................................................................................................................................</p><p>Diagnosis: / _____ / (1 = etiology found, 2 = year)</p></sec></body><back><ref-list><title>References</title><ref id="scirp.96377-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">OMS (2017) Santé mentale et vieillissement. WHO.  
http://www.who.int/mediacentre/factsheets/fs381/fr/</mixed-citation></ref><ref id="scirp.96377-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Beghe, C., Ershler, W.B. and Wilson, A. (2004) Prevalence and Outcomes of Anemia in Geriatrics: A Systematic Review of the Literature. The American Journal of Medicine, 116, 3-10. https://doi.org/10.1016/j.amjmed.2003.12.009</mixed-citation></ref><ref id="scirp.96377-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">WHO (2017) Haemoglobin Concentrations for the Diagnosis of Anaemia and Assessment of Severity. WHO.  
http://www.who.int/vmnis/indicators/haemoglobin/en/</mixed-citation></ref><ref id="scirp.96377-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Izaks, G.J., Westendorp, R.G. and Knook, D.L. (1999) The Definition of Anemia in Older Persons. The Journal of the American Medical Association, 281, 1714-1717.  
https://doi.org/10.1001/jama.281.18.1714</mixed-citation></ref><ref id="scirp.96377-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Gómez Ramírez, S., RemachaSevilla, á.F. and Munoz Gómez, M. (2017) Anaemia in the Elderly. Medicina Clínica, 149, 496-503. 
https://doi.org/10.1016/j.medcle.2017.10.027</mixed-citation></ref><ref id="scirp.96377-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">WHO (2017) Anaemia Data by Country. WHO.  
http://www.who.int/vmnis/database/anaemia/countries/en/</mixed-citation></ref><ref id="scirp.96377-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Dembele, O.S. (1980) Etude hématologique et étiologique des anémies en médecine interne à Bamako. Bamako, 13.</mixed-citation></ref><ref id="scirp.96377-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Sandji, O. (2015) Evaluation multidimensionnelle du sujet agé de 65 ans et plus en service de médecine interne du CHU Point G. Bamako, 193.</mixed-citation></ref><ref id="scirp.96377-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Netgen (2018) L’anémie du sujet agé: Une pathologie fréquente à ne pas banaliser. Revue Médicale Suisse.  
https://www.revmed.ch/RMS/2010/RMS-270/L-anemie-du-sujet-age-une-pathologie-frequente-a-ne-pas-banaliser</mixed-citation></ref><ref id="scirp.96377-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Levy, C. and Siguret, V. (2007) L’anémie du sujet agé: Une étiologie peut en cacher une autre! Immuno-analyse &amp; Biologie Spécialisée, 22, 215-221.  
https://doi.org/10.1016/j.immbio.2007.07.001</mixed-citation></ref><ref id="scirp.96377-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Callera, F., Callera, A.F., da Silva, A.M. and Rosa, E.S. (2015) Prevalence of Anemia in a Sample of Elderly Southeastern Brazilians. Revista Brasileira de Hematologia e Hemoterapia, 37, 43-47. https://doi.org/10.1016/j.bjhh.2014.06.005</mixed-citation></ref><ref id="scirp.96377-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Beyne-Ranzy, O., Castex, A., Lapoujade, B., Vellas, B. and Adoue, D. (2007) Anémie du Sujet agé: Une fréquence élevée et de nombreuses causes associées. La Revue de Médecine Interne, 28, S36-S82. https://doi.org/10.1016/j.revmed.2007.03.059</mixed-citation></ref><ref id="scirp.96377-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Tolo, N. (2013) Anémie chez le sujet agé: étude des aspects épidémiologiques, cliniques et étiologiques dans le service de Médecine Interne du CHU Point G. Mémoire: Med, Bamako.</mixed-citation></ref><ref id="scirp.96377-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Roth, S., Obrecht, V., Putetto, M., Miniconi, Z., Chaillou-Opitz, S. and Pesce, A. (2009) Anémies du sujet agé: Expérience d’un service de gériatrie et recommandations. La Revue de Médecine Interne, 30, S77-S151. 
https://doi.org/10.1016/j.revmed.2009.03.230</mixed-citation></ref><ref id="scirp.96377-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Zulfiqar, A.A., Seng, X.S., Gilibert, A., Kadri, N., Doucet, J. and Andres, E. (2018) Anémie chez le sujet agé: Etude des liens avec les critères gériatriques. La Revue de Médecine Interne, 39, A245. https://doi.org/10.1016/j.revmed.2018.03.260</mixed-citation></ref></ref-list></back></article>